Empiric use of anticoagulation in hospitalized patients with COVID-19: a propensity score-matched study of risks and benefits
Research
[키워드] 95% CI
95% confidence interval
Admission
Analysis
anticoagulation
association
Atrial fibrillation
baseline characteristics
benefit
bleeding
Clinical data
Cohort
cohorts
COVID-19
COVID-19 patients
D-dimer level
Escalation
HAS-BLED
hazard ratio
High-risk patients
higher risk
Hospitalized
hospitalized patient
incidence
independent
indication
intensity
Invasive mechanical ventilation
low dose
lower mortality
major bleeding
median
Mortality
no difference
no significant difference
non-critically ill patient
outcome
parameter
Patient
patients
patients hospitalized
patients with COVID-19
performed
Primary outcome
Propensity score
propensity score matching
Prophylactic
receiving
Result
Retrospective analysis
risk
subgroup
supplementary material
survival
therapeutic
Thromboembolic event
Thromboembolism
was performed
were excluded
[DOI] 10.1186/s40364-021-00283-y PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s40364-021-00283-y PMC 바로가기 [Article Type] Research